A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects With Chronic Anovulation Using the Gonal-f® Prefilled Pen in Women Undergoing Ovulation Induction (LoGo)

NCT01871532 Phase 4 TERMINATED Results posted

This is a prospective, multicenter, open-label, comparative and parallel-group study of ovulation induction evaluating tailoring of Recombinant follicle stimulating hormone (FSH) treatment using the Gonal-f® prefilled pen in World Health Organization (WHO) Type 2 anovulatory subjects who have previously failed to conceive with clomifene treatment.

Details

Lead sponsor	Merck KGaA, Darmstadt, Germany
Phase	Phase 4
Status	TERMINATED
Enrolment	24
Start date	2013-07
Completion	2014-11

Conditions

• Infertility
• Monofollicular Development

Interventions

• Gonal-f®

Primary outcomes

• Percentage of Cycles With Monofollicular Development — Baseline up to 4 weeks
  The monofollicular development was defined as the number of cycles with monofollicular development only one Follicle Greater Than or Equal (\>= to 17 millimeter (mm) and no other follicles Greater than or equal to 14 mm following up to 4 weeks Gonal-f treatment.

Countries

Ireland, United Kingdom